1. Home
  2. BNR vs MNY Comparison

BNR vs MNY Comparison

Compare BNR & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • MNY
  • Stock Information
  • Founded
  • BNR 2014
  • MNY 2014
  • Country
  • BNR China
  • MNY Singapore
  • Employees
  • BNR N/A
  • MNY N/A
  • Industry
  • BNR Medical Specialities
  • MNY
  • Sector
  • BNR Health Care
  • MNY
  • Exchange
  • BNR Nasdaq
  • MNY Nasdaq
  • Market Cap
  • BNR 29.1M
  • MNY 31.0M
  • IPO Year
  • BNR 2020
  • MNY N/A
  • Fundamental
  • Price
  • BNR $3.10
  • MNY $0.74
  • Analyst Decision
  • BNR
  • MNY
  • Analyst Count
  • BNR 0
  • MNY 0
  • Target Price
  • BNR N/A
  • MNY N/A
  • AVG Volume (30 Days)
  • BNR 68.0K
  • MNY 19.0K
  • Earning Date
  • BNR 06-10-2025
  • MNY 06-13-2025
  • Dividend Yield
  • BNR N/A
  • MNY N/A
  • EPS Growth
  • BNR N/A
  • MNY N/A
  • EPS
  • BNR N/A
  • MNY N/A
  • Revenue
  • BNR $70,669,261.00
  • MNY $79,510,746.00
  • Revenue This Year
  • BNR $136.32
  • MNY $31.98
  • Revenue Next Year
  • BNR N/A
  • MNY $10.97
  • P/E Ratio
  • BNR N/A
  • MNY N/A
  • Revenue Growth
  • BNR N/A
  • MNY N/A
  • 52 Week Low
  • BNR $2.18
  • MNY $0.55
  • 52 Week High
  • BNR $7.90
  • MNY $2.75
  • Technical
  • Relative Strength Index (RSI)
  • BNR 51.73
  • MNY 48.05
  • Support Level
  • BNR $2.99
  • MNY $0.70
  • Resistance Level
  • BNR $3.45
  • MNY $0.76
  • Average True Range (ATR)
  • BNR 0.34
  • MNY 0.04
  • MACD
  • BNR 0.10
  • MNY 0.00
  • Stochastic Oscillator
  • BNR 70.59
  • MNY 40.40

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.

Share on Social Networks: